FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20200529E00091
1. Date of relevant event: 26/05/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 03681
4. Name of listed corporation: SinoMab BioScience Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,006,240,400
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Qiang
(Other names) Jing
10. Name of director (Chinese): 強靜 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1101The number of shares in which you are interested has increased because:
you purchased the shares
 
 
2201Interest of corporation controlled by you
 		 41,331,640  HKD      3.5000 
3101Cash
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position212,889,40021.16
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position254,221,04025.26
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position41,331,640
2202Interest of your spouse
Long position212,889,400
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
SpouseLIU WENYI 刘文溢
Long position212,889,400
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
上海杏泽投资管理有限公司上海市虹口区东大名路391-393号(单号)223室 (中国上海）刘文溢21.16N
Long position212,889,400
上海月溢投资中心（有限合伙）上海市青浦区五厍浜路201号13幢一层C区158室 (中国上海)刘文溢21.16N
Long position212,889,400
上海杏泽兴瞻企业管理中心（有限合伙）中国（上海）自由贸易试验区浦东大道2123号三楼西南区(中国上海）上海杏泽投资管理有限公司7.19N
Long position72,349,000
West Biolake Holdings (HK) LimitedUnits 303 and 305 to 307,No.15 Science Park West Avenue,Hong Kong Science Park, Pak Shek Kok, New Territories,Hong Kong (Hongkong)上海杏泽兴瞻企业管理中心（有限合伙）7.19N
Long position72,349,000
West Biolake Holdings Limited30 de Castro Street,Wickhams Cay 1,P.O.Box 4519,Road Town,Tortola,British Virgin Islands(British Virgin Islands)West Biolake Holdings(HK) Limited7.19Y
Long position72,349,000
上海健益兴禾创业投资中心（有限合伙）中国(上海)自由贸易试验区浦东大道2123号3E-2810室 (中国上海）上海杏泽投资管理有限公司10.76N
Long position108,316,600
上海杏泽兴禾创业投资中心（有限合伙）中国(上海)自由贸易试验区浦东大道2123号三楼西南区 (中国上海）上海杏泽投资管理有限公司及上海月溢投资中心（有限合伙）10.76N
Long position108,316,600
Apricot Oversea Holdings LimitedUnits 303 and 305 to 307,No.15 Science Park West Avenue,Hong Kong Science Park, Pak Shek Kok, New Territories,Hong Kong (Hongkong)上海杏泽兴禾创业投资中心（有限合伙）及上海健益兴禾创业投资中心（有限合伙）10.76N
Long position108,316,600
Apricot Oversea Holdings Limited30 de Castro Street,Wickhams Cay 1,P.O.Box 4519,Road Town,Tortola,British Virgin Islands (British Virgin Islands)Apricot Oversea Holdings Limited10.76Y
Long position108,316,600
Grogene Technology Limited6/F, Carson Commercial Centre, 333 Nathan Road, Jordan, Kowloon, Hong Kong強靜100.00Y
Long position41,331,640
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Pursuant to the Sale and Purchase Agreement dated 26 May 2020 made between, among others, Forbest Capital Investment Group Limited ("Forbest Capital") and Grogene Technology Limited ("Grogene"), Forbest Capital agreed to sell 41,331,640 shares of SinoMab BioScience Limited to Grogene at a price of HK$3.50 per share. Completion of the said Agreement is conditional upon all the Conditions (as defined threin) having been satisfied as stipulated therein.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 29/05/2020
(dd/mm/yyyy)